- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06768060
Mindfulness-based Intervention Prior to External Cephalic Version
March 17, 2026 updated by: Simone Kuppens, Catharina Ziekenhuis Eindhoven
Preparing Mothers for External Cephalic Version: a Mindfulness-based Intervention for Pregnant Women With a Baby in Breech Presentation
The study is a randomized controlled trial examining the effectiveness of a short mindfulness-based intervention on the success rate of external cephalic version in pregnant women with breech presentation.
It is hypothesized that this intervention will increase the ECV success rate and decrease the pain experienced after the ECV.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
148
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Simone MI Kuppens, MD, PhD
- Phone Number: 0031402399300
- Email: simone.kuppens@catharinaziekenhuis.nl
Study Contact Backup
- Name: Lianne P Hulsbosch, PhD
- Phone Number: 0134664213
- Email: l.p.hulsbosch@tilburguniversity.edu
Study Locations
-
-
North Brabant
-
Eindhoven, North Brabant, Netherlands, 5623 EJ
- Recruiting
- Catharina Hospital
-
Contact:
- Simone MI Kuppens, MD, PhD
- Phone Number: 0031402399300
- Email: simone.kuppens@catharinaziekenhuis.nl
-
Contact:
- Lianne P Hulsbosch, PhD
- Phone Number: 0134664213
- Email: l.p.hulsbosch@tilburguniversity.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Pregnant women (18+y).
- With a breech presenting fetus undergoing external cephalic version.
- Dutch/English-speaking or understanding Dutch/English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Care as usual
|
|
|
Experimental: Intervention group
Short mindfulness-based intervention (5 minutes) prior to the external cephalic version
|
The intervention includes a short mindfulness-based intervention with a duration of 5 minutes.
It involves a sitting mediation focused on breath adapted from the existing protocols of the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT).
The intervention is audio-guided and will be delivered via headphones.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-intervention external cephalic version success rate
Time Frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
The success rate of the external cephalic versions (successful/not successful) will be compared between the intervention and control group.
|
1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-intervention pain perception
Time Frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
The pain experienced during the external cephalic version will be assessed with a visual analogue scale (VAS).
The mean/median VAS scores will be compared between the intervention and control group.
The scores range between 0 and 10, with a higher score indicating more experienced pain.
|
1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
|
Post-intervention comfort
Time Frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Comfort during the external cephalic version will be assessed with a visual analogue scale (VAS).
The mean/median VAS scores will be compared between the intervention and control group.
The scores range between 0 and 10, with a higher score indicating more comfort.
|
1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline mindfulness skills
Time Frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
Baseline mindfulness skills are assessed with the 15-item Three Facet Mindfulness Questionnaire Short Form (TFMQ-SF), consisting of the facets acting with awareness, non-judging and non-reacting.
The total score ranges from 0 to 60, with higher scores indicating better mindfulness skills.
The validity of the measure is established and indices of internal reliability were found to be adequate.
|
At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
|
Baseline depressive symptoms
Time Frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
Assessed with the 10-item Edinburgh Postnatal Depression Scale (EPDS).
The EPDS is the most widely used self-rating scale to assess depressive symptoms in the perinatal period.
The EPDS total score ranges from 0 to 30, with higher scores indicating more depressive symptoms.
The questionnaire has been validated in Dutch postpartum women.
|
At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
|
Baseline fear of external cephalic version
Time Frame: At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
Assessed with a visual analogue skill (VAS), by which participants indicate how anxious they feel about the upcoming external cephalic version.
The scores range from 0 to 10, with higher scores indicating more anxiety about the upcoming external cephalic version.
|
At baseline (i.e., in hospital, prior to intervention and external cephalic version)
|
|
Post-intervention general questions
Time Frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Three general questions about the information that women received during the external cephalic version, and the familiarity with mindfulness/yoga.
|
1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
|
Post-intervention evaluation of the intervention
Time Frame: 1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Four questions about how women perceived the intervention (intervention group only)
|
1 hour after enrollment (i.e., in hospital, after intervention and external cephalic version)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2025
Primary Completion (Estimated)
January 31, 2028
Study Completion (Estimated)
January 31, 2028
Study Registration Dates
First Submitted
December 17, 2024
First Submitted That Met QC Criteria
January 6, 2025
First Posted (Actual)
January 10, 2025
Study Record Updates
Last Update Posted (Actual)
March 18, 2026
Last Update Submitted That Met QC Criteria
March 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- W24.245
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on External Cephalic Version
-
Yaakov BeilinTerminatedExternal Cephalic VersionUnited States
-
University of Milano BicoccaCompletedExternal Cephalic Version | Maternal Oral HydrationItaly
-
Icahn School of Medicine at Mount SinaiTerminated
-
Columbia UniversityTerminatedAnalgesia Management for External Cephalic VersionUnited States
-
University of North Carolina, Chapel HillCompleted
-
AdventHealthTerminatedBreech Presentation | External Cephalic VersionUnited States
-
Hospital de CrucesCompletedPregnancy Complications | Inhalation of Nitrous Oxide | Complications; Cesarean Section | Non-cephalic Presentation | Fetus or Neonate Affected by External Version Before LaborSpain
-
Herning HospitalCompletedPresentation; Breech, With External Version Before Labor
-
Catharina Ziekenhuis EindhovenTilburg UniversityCompletedStress, Psychological | Congenital Hip Dysplasia | Breech Presentation | Thyroid Hormones | External Cephalic VersionNetherlands
-
Tel-Aviv Sourasky Medical CenterUnknownCephalic Phase, Oncology PatientsIsrael
Clinical Trials on Short mindfulness-based intervention
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore
-
Jordan University of Science and TechnologyCompleted
-
Hospital Miguel ServetCompleted
-
Jordan University of Science and TechnologyNot yet recruitingEnd-Stage Kidney DiseaseJordan
-
Universidad Autonoma de Baja CaliforniaEnrolling by invitationAnxiety Depression (Mild or Not Persistent)Mexico
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
University of PisaCompletedDepression | Anxiety | Child, Only | TemperamentItaly
-
Pediatric Clinical Research PlatformActive, not recruitingCognitive Dysfunction | Preterm Birth | Behavioral Problem